Name | 1,4-Dihydro-2,6-dimethyl-3-nitro-4-(2-trifluoromethylphenyl)-pyridine-5-carboxylic acid methyl ester |
---|---|
Synonyms |
(1,4-dihydro-2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)-phenyl]-3-pyridine carboxylic acid methyl ester
rac-Aziridin-2-carbonitril methyl-1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-trifluoromethylphenyl)-pyridine-3-carboxylate (+/-)-Aziridin-2-carbonitril cyano-2 aziridine (-)-2,6-dimethyl-3-carbomethoxy-5-nitro-4-(2-trifluoromethylphenyl)-1,4-dihydropyridine 2-aziridinecarbonitrile MFCD00036697 2-cyano-2-aziridine (.+/-.)-Bay K 8644 nitrile of aziridine-2-carboxylic acid Bay K-8644 |
Description | Bay K 8644, a dihydropyridine compound, is a specific L-type Ca2+ channel agonist. Bay K 8644 increases Ca2+ influx through sarcolemmal Ca2+ channels by increasing the open time of the channel[1]. |
---|---|
Related Catalog | |
In Vitro | In newborn rat ventricular cardiomyocytes, Bay K 8644 (1 μM) treatment increases L-type calcium current density in 2-day-old cells. The higher increase of L-type calcium current density by Bay K 8644 in 2-day- than in 7-day-old cultured cells could be interpreted as the result of a difference in the phosphorylation level of calcium channels for each stage of development[2]. |
In Vivo | A one time dose as low as 10 μg/kg of Bay K 8644 significantly elevates mean arterial pressure (MAP) in endotoxin-treated hypotensive rats while having minimal effects in normal rats. Bay K 8644 also causes a dose-dependent decrease in heart rate of 37% in endotoxin-treated rats and 39% in control rats[1]. |
References |
Density | 1.37g/cm3 |
---|---|
Boiling Point | 404.3ºC at 760 mmHg |
Molecular Formula | C16H15F3N2O4 |
Molecular Weight | 356.29700 |
Flash Point | 198.3ºC |
Exact Mass | 356.09800 |
PSA | 84.15000 |
LogP | 4.19940 |
Index of Refraction | 1.545 |
Storage condition | -20℃ |
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H315-H319 |
Precautionary Statements | P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xi |
Risk Phrases | 36/38 |
Safety Phrases | 26-36 |
RIDADR | NONH for all modes of transport |
~37% 71145-03-4 |
Literature: Bayer Aktiengesellschaft Patent: US4532248 A1, 1985 ; |
~33% 71145-03-4 |
Literature: Gorlitzer; Schmidt Archiv der Pharmazie, 1991 , vol. 324, # 10 p. 785 - 796 |
~21%
Detail
|
Literature: Gorlitzer; Schmidt Archiv der Pharmazie, 1991 , vol. 324, # 10 p. 785 - 796 |
Precursor 4 | |
---|---|
DownStream 0 |